- Home
- JDZG vs COCP Comparison
JDZG vs COCP Comparison
Compare JDZG & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JDZG
- COCP
- Stock Information
- Founded
- JDZG 2020
- COCP 2006
- Country
- JDZG China
- COCP United States
- Employees
- JDZG N/A
- COCP N/A
- Industry
- JDZG Other Consumer Services
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- JDZG Real Estate
- COCP Health Care
- Exchange
- JDZG Nasdaq
- COCP Nasdaq
- Market Cap
- JDZG 18.4M
- COCP 15.3M
- IPO Year
- JDZG 2024
- COCP N/A
- Fundamental
- Price
- JDZG $0.53
- COCP $1.52
- Analyst Decision
- JDZG
- COCP Strong Buy
- Analyst Count
- JDZG 0
- COCP 1
- Target Price
- JDZG N/A
- COCP $7.00
- AVG Volume (30 Days)
- JDZG 530.0K
- COCP 12.6K
- Earning Date
- JDZG 05-20-2025
- COCP 05-20-2025
- Dividend Yield
- JDZG N/A
- COCP N/A
- EPS Growth
- JDZG N/A
- COCP N/A
- EPS
- JDZG 0.03
- COCP N/A
- Revenue
- JDZG $2,567,741.00
- COCP N/A
- Revenue This Year
- JDZG N/A
- COCP N/A
- Revenue Next Year
- JDZG N/A
- COCP N/A
- P/E Ratio
- JDZG $17.04
- COCP N/A
- Revenue Growth
- JDZG 20.36
- COCP N/A
- 52 Week Low
- JDZG $0.45
- COCP $1.12
- 52 Week High
- JDZG $15.08
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- JDZG N/A
- COCP 51.20
- Support Level
- JDZG N/A
- COCP $1.36
- Resistance Level
- JDZG N/A
- COCP $1.74
- Average True Range (ATR)
- JDZG 0.00
- COCP 0.18
- MACD
- JDZG 0.00
- COCP 0.01
- Stochastic Oscillator
- JDZG 0.00
- COCP 50.00
About JDZG JIADE LIMITED Common stock
Jiade Ltd Ltd is engaged in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platforms and auxiliary solutions. The Group offers pre-enrollment guidance on school/selection and application development, training for entrance exams, and assistance in the application process. The Group also offers offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance in the People's Republic of China.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).